Evidence map›Paper›PMID 22377034›Full record

ArticleEmerging infectious diseases2012

Laboratory practices and incidence of non-O157 shiga toxin-producing Escherichia coli infections.

Kathleen A Stigi, J Kathryn Macdonald, Anthony A Tellez-Marfin, Kathryn H Lofy

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Shiga Toxin-ProducingMicroorganisms · 2025
    Article
  2. Article
  3. Shiga Toxin-ProducingMicroorganisms · 2021
    Article
  4. Improved Genomic Identification, Clustering, and Serotyping of Shiga Toxin-ProducingFrontiers in cellular and infection microbiology · 2021
    Article
  5. Article
  6. Shiga Toxin (Verotoxin)-producingFood safety (Tokyo, Japan) · 2017
    Review
  7. Article
  8. Article
  9. Non-O157:H7 Shiga Toxin Producing DiarrhoeagenicJournal of clinical and diagnostic research : JCDR · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Nonculture diagnostic tests for enteric diseases.Emerging infectious diseases · 2012
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Kathleen A StigiWashington State Department of Health, Shoreline, WA 98155, USA. katie.stigi@doh.wa.gov
J Kathryn Macdonald
Anthony A Tellez-Marfin
Kathryn H Lofy

Funding

NCHM CDC HHS 5U38HM000414NCHM CDC HHS U38 HM000414
6 · The paper itself

Abstract

We surveyed laboratories in Washington State, USA, and found that increased use of Shiga toxin assays correlated with increased reported incidence of non-O157 Shiga toxin-producing Escherichia coli (STEC) infections during 2005-2010. Despite increased assay use, only half of processed stool specimens underwent Shiga toxin testing during 2010, suggesting substantial underdetection of non-O157 STEC infections.

Indexed as

LaboratoriesMicrobiologyBacteriological TechniquesEscherichia coli InfectionsHumansIncidenceShiga-Toxigenic Escherichia coliWashington

Identifiers

PMID22377034
PMCPMC3309587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.